Chapter 2: Pharmacokinetic & Pharmacodynamic Principles

Pharmacokinetics involves four key processes: absorption, distribution, metabolism, and elimination. Absorption dictates the drug's bioavailability, or the percentage that reaches systemic circulation, and is heavily influenced by the route of administration, drug solubility (hydrophilic or hydrophobic), and presystemic degradation, notably the first-pass effect in the liver, which is especially relevant for orally administered agents. Drug distribution depends on tissue blood flow, lipid solubility, and protein binding; only the unbound, or free, drug can achieve a pharmacologic effect. The volume of distribution (Vd) is a mathematically determined value reflecting how widely the drug spreads throughout the body's compartments. Elimination combines hepatic metabolism and renal excretion. Metabolism, primarily mediated by liver enzymes, including the Cytochrome P-450 (CYP) system, modifies drugs into more water-soluble forms, but this process can be dramatically altered by enzyme induction or inhibition, leading to crucial drug–drug interactions. Renal clearance is estimated using surrogate markers like creatinine, often calculated via the Cockcroft-Gault (CG) or Modification of Diet in Renal Disease (MDRD) equations, which is vital for adjusting doses in patients with impaired function. Important PK concepts like half-life (t 21 ) determine the rate of elimination and the time required (typically three to five half-lives) to reach steady state, necessitating the use of a loading dose when a therapeutic level is quickly required. Pharmacodynamics explains drug action through ligands binding to receptors (such as gated ion channels, transmembranous, G protein-coupled, or intracellular). The drug’s affinity for a receptor determines its potency, and its functional role is defined as an agonist (stimulator) or an antagonist (blocker). Ultimately, achieving therapeutic goals requires understanding the dose-response relationship within the therapeutic window. Practitioners must integrate these principles while considering individual patient factors—including age, sex, ethnicity, diet, genetics (pharmacogenomics), and pathophysiology—as these variables cause significant deviations from standard drug responses.